Search hospitals > Nevada > Henderson

Las Vegas Urology - Pecos

Claim this profile
Henderson, Nevada 89074
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Tumors
Conducts research for Breast Cancer
Conducts research for Adenocarcinoma
90 reported clinical trials
2 medical researchers
Photo of Las Vegas Urology - Pecos in HendersonPhoto of Las Vegas Urology - Pecos in HendersonPhoto of Las Vegas Urology - Pecos in Henderson

Summary

Las Vegas Urology - Pecos is a medical facility located in Henderson, Nevada. This center is recognized for care of Cancer, Lung Cancer, Tumors, Breast Cancer, Adenocarcinoma and other specialties. Las Vegas Urology - Pecos is involved with conducting 90 clinical trials across 256 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.

Area of expertise

1Cancer
Global Leader
Las Vegas Urology - Pecos has run 46 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I
2Lung Cancer
Global Leader
Las Vegas Urology - Pecos has run 16 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage III

Top PIs

Clinical Trials running at Las Vegas Urology - Pecos

Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Cancer
Bladder Carcinoma
Gastric Cancer
Renal Cell Carcinoma
Esophageal Cancer
Anal Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Chemotherapy Reduction After Surgery

for Breast Cancer

This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Image of trial facility.

Symptom Monitoring

for Young Women on Hormone Therapy

This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Las Vegas Urology - Pecos?
Las Vegas Urology - Pecos is a medical facility located in Henderson, Nevada. This center is recognized for care of Cancer, Lung Cancer, Tumors, Breast Cancer, Adenocarcinoma and other specialties. Las Vegas Urology - Pecos is involved with conducting 90 clinical trials across 256 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.